Matches in Nanopublications for { ?s ?p " Sacubitril is used in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) It is usually administered in conjunction with other heart failure therapies, in place of an ACE inhibitor or other ARB. It is also used in. combination with. an ACE. inhibitor or an ARB, it is usually used in conjunction." ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- assertion wasQuotedFrom " Sacubitril is used in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) It is usually administered in conjunction with other heart failure therapies, in place of an ACE inhibitor or other ARB. It is also used in. combination with. an ACE. inhibitor or an ARB, it is usually used in conjunction." provenance.